
Cagrilintide
A 37-amino acid long-acting acylated amylin analog that activates amylin and calcitonin receptors to modulate appetite signaling in homeostatic and hedonic brain regions, studied in clinical trials for weight management. Premium Research Peptide.
$69.99
|
10MG
|
Verified Test Results
Every batch, independently verified.
Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory. The report below reflects the identity, purity and full-panel specification data released with this product.
Certificate of Analysis
Purity by HPLC
| Parameter | Result | Method | Specification |
|---|---|---|---|
| Appearance | Good | Visual | Meets spec |
| Purity | 99.84% · Pass | HPLC | ≥ 95% |
| Net Peptide Content | 10.61mg | HPLC | Report |
| Identity | Confirmed | HPLC | Meets spec |
| Fentanyl Screen | Not Detected | Immunoassay | Pass |
| Heavy Metals | Not Detected | ICP-MS | Pass |
| Sterility | No Growth | PCR | Pass |
| Endotoxin | 0.103 EU/mL | USP <85> | Reported |
Representative report from lot CAG0002 (Cagrilintide). Your order ships with its own lot-specific certificate.
View this batch's certificateThird-party verified
Certificate of Analysis
Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch's certificate below.
Cagrilintide 10mg
LatestLOT CAG0002
HPLC purity · meets spec
- Labeled
- 10mg
- Measured
- 10.61mg
- Identity
- Confirmed
- Heavy metals
- Not Detected
- Sterility
- No Growth
- Endotoxin
- 0.103 EU/mL
- Tested
- Jul 30, 2026
8 assays passed · ISO/IEC 17025 accredited
View certificateCagrilintide 10mg
LOT CAG0001
HPLC purity · meets spec
- Labeled
- 10mg
- Measured
- 10.42mg
- Identity
- Cagrilintide
- Heavy metals
- Not Detected
- Sterility
- No Growth
- Endotoxin
- < 0.05 EU/mL
- Tested
- May 29, 2026
7 assays passed · ISO/IEC 17025 accredited
View certificateCompound Information
Technical specifications
What Is Cagrilintide?
Stability Information
Sources & References
Peer-reviewed research
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
Garvey WT, Blüher M, Osorto Contreras CK et al.
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
Lau DCW et al.
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial
Enebo LB et al.
Structural and dynamic features of cagrilintide binding to calcitonin-family receptors
Development of Cagrilintide, a Long-Acting Amylin Analogue
Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity
D'Ascanio AM, Mullally JA, Frishman WH
Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3
Cagrilintide — CID 171397054
CagriSema demonstrated superior HbA1c reduction of 1.91%-points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 trial
REDEFINE 1 — A Research Study to See How Well CagriSema Works in People Living With Overweight or Obesity
⚠️ Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
Frequently asked questions
A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.
Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.
A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.
Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.